David A. Siegel Mirati Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $1.04 Million - $2.36 Million	26,600 Added 190.0%	40,600 $2.73 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $932,585 - $1.86 Million	-12,300 Reduced 46.77%	14,000 $1.15 Million
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $1.9 Million - $2.74 Million	-14,400 Reduced 35.38%	26,300 $3.86 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $3.74 Million - $5.02 Million	-28,300 Reduced 41.01%	40,700 $7.2 Million
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $9.16 Million - $11.4 Million	-63,600 Reduced 47.96%	69,000 $11.1 Million

Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $317,840 - $443,220	-2,000 Reduced 1.49%	132,600 $22.7 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $7.94 Million - $11.8 Million	49,000 Added 57.24%	134,600 $29.6 Million
Q3 2020 Nov 16, 2020	SELL	$113.26 - $167.27 $3.65 Million - $5.39 Million	-32,200 Reduced 27.33%	85,600 $14.2 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $597,683 - $999,237	8,300 Added 7.58%	117,800 $13.4 Million
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $5.65 Million - $9.4 Million	-80,900 Reduced 42.49%	109,500 $8.42 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $198,128 - $360,808	2,800 Added 1.49%	190,400 $24.5 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $1.61 Million - $2.27 Million	20,700 Added 12.4%	187,600 $14.6 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $3.62 Million - $6.37 Million	60,800 Added 57.3%	166,900 $17.2 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $807,525 - $1.46 Million	18,500 Added 21.12%	106,100 $7.78 Million
Q4 2018 Feb 14, 2019	BUY	$32.0 - $47.43 $224,000 - $332,010	7,000 Added 8.68%	87,600 $3.72 Million
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $2.57 Million - $3.42 Million	54,600 Added 210.0%	80,600 $3.8 Million
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $677,300 - $1.36 Million	26,000 New	26,000 $1.28 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account